News | April 21, 2010

Force Sensing Ablation Catheter Calculates Pressure Applied


April 21, 2010 – A second generation, force-sensing ablation catheter released this week in Europe, gives physicians a real-time, objective measure of contact force during the treatment of cardiac arrhythmias. It includes a smaller fiber optic sensor at the tip, a force-time integral display and automatically generated summary reports of the procedure.

The next generation TactiCath force-sensing ablation catheter was recently granted CE mark and unveiled at German Cardiac Society meeting in Mannheim, Germany.

The catheter includes a support system called the TactiSys. It is comprised of a graphical user interface, base station and splitter. It includes a customizable, information-rich user interface that now displays force-time integral (the calculation of force over time), a new parameter which research has shown may be a better predictor of lesion size than current alternative parameters. The system automatically generates summary reports that document therapy delivery, including a histogram that shows physicians the forces applied throughout the catheter ablation procedure.

“I find the next generation product to be a significantly enhanced system that delivers even greater performance and flexibility during catheter ablation procedures,” said Dipen Shah, M.D., University Hospital of Geneva, Switzerland. “The new features and product enhancements make the TactiCath and TactiSys an even more compelling addition to the EP lab.”

The new TactiCath and TactiSys are indicated for the treatment of atrial fibrillation (AF) and supraventricular tachycardia (SVT). The product is currently available in markets across Europe, Latin America, Canada, the Middle East and Africa.

For more information: www.endosense.com


Related Content

News

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...

Home October 10, 2023
Home
News

August 9, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

Home August 09, 2023
Home
News

January 31, 2023 —Imricor, a global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation ...

Home January 31, 2023
Home
News

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022
Home
News

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

Home October 24, 2022
Home
News

May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

Home May 13, 2022
Home
News

May 4, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias ...

Home May 04, 2022
Home
News

April 5, 2021 — Acutus Medical today announced initial U.S. enrollments in the company’s AcQForce Flutter ...

Home April 05, 2021
Home
News

June 16, 2020 – The Montreal Heart Institute (MHI) and Thermedical, a developer of thermal-ablation systems to treat ...

Home June 16, 2020
Home
News

May 8, 2020 – Results from a first-in-human early feasibility study (EFS) using a saline enhanced radiofrequency (SERF) ...

Home May 08, 2020
Home
Subscribe Now